Рет қаралды 13,111
Dr. Tomás Duraj, Physician/Scientist at the Seyfried Lab, discusses the most pivotal results from Lab's study on the use of ketogenic metabolic therapy against glioblastoma.
Read The Full Paper: Duraj, T., Kalamian, M., Zuccoli, G. et al. Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma. BMC Med 22, 578 (2024). doi.org/10.118...
Follow Dr. Seyfried on X: x.com/tnseyfried